TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
AMPH

Amphastar Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

27.40$ +4.8% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Amphastar Pharmaceuticals, Inc. (AMPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,629 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AMPH
Line item 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – 317 339 389 390 428 455 514 587 631 672 742 1,513 1,577 1,629
– – 166 173 198 176 184 188 220 255 280 318 378 490 534 636
– – 50 54 68 66 72 66 86 76 93 126 156 144 152 170
– – 50 54 68 66 73 68 89 90 106 137 176 257 222 283
– – 38 25 23 33 27 36 52 45 66 79 89 115 138 144
– – 51 70 82 71 80 64 69 111 97 93 104 106 154 177
– – 107 117 138 142 153 185 210 234 260 244 238 – – –
– – 0.3 0.3 4.5 3.7 4.0 4.5 4.0 3.6 3.9 3.3 3.1 3.2 3.0 3.4
– – 42 40 38 36 46 41 38 38 37 36 34 610 588 563
– – 84 87 108 95 98 117 149 159 183 226 213 873 845 840
– – 60 65 63 60 61 67 107 90 112 104 95 225 174 158
– – 22 22 7.6 11 5.4 6.3 18 11 16 5.2 6.0 4.3 7.0 9.6
– – 18 20 10 14 20 17 31 25 24 22 21 25 31 33
– – 16 10 36 30 32 41 32 39 34 75 73 590 602 609
– – 233 252 282 296 329 337 332 381 402 446 529 639 732 789
– – 62 74 63 60 71 76 67 116 118 180 272 409 569 667
39 8.0 8.0 8.0 42 45 48 48 46 50 49 50 52 53 52 48

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?